Clinical Summary
Clinical Summary: Depression and Cardiovascular Burden in Aging Populations: Insights From the National Health and Nutrition Examination Survey 2010–2020 on Symptom Frequency, Sociodemographic Disparities, and Modifiable Risk Factors
Older adults with cardiovascular disease often present with overlapping somatic and mood symptoms, making depression easy to miss in routine care. This study shows that even brief, frequency-based depressive symptom reporting tracks with higher cardiovascular burden, especially when obesity or smoking are also present.
Design
This cross-sectional analysis employed data from the NHANES, conducted by the Centers for Disease Control and Prevention.
N
the final analytic cohort comprised 16,257 participants
Population
individuals aged ≥50 years
Duration
survey cycles spanning 2010 to March 2020 pre–COVID-19 pandemic
Key Findings
- Overall, 8.5% reported a history of CVD, and participants categorized as having depressive symptoms had higher prevalence of CHD (10.8% vs 8.4%), angina (14.6% vs 11.7%), MI (15.4% vs 12.3%), and CHF (12.5% vs 9.1%) than nondepressed participants (all P <.001).
- A symptom-frequency gradient was seen across CVD subtypes: CHD prevalence rose from 7.3% in the “not at all” group to 10.6% (“several days”), 10.9% (“more than half the days”), and 18.2% (“nearly every day”), while angina rose from 3.7% to 8.5%, 7.7%, and 13.6%; all trend tests across frequency categories were statistically significant (P < .001).
- MI prevalence increased from 7.0% in the “not at all” group to 13.5% (“several days”), 11.4% (“more than half the days”), and 13.6% (“nearly every day”), and CHF prevalence was 5.1%, 12.3%, 7.1%, and 4.5%, respectively; all trend tests across frequency categories were statistically significant (P < .001).
- Depressive symptoms combined with obesity were associated with markedly higher cardiovascular odds: participants with depressive symptoms and a BMI ≥30 kg/m2 had 3.2 times higher odds of having CHD or angina and 3.1 times higher odds of having CHF or MI than individuals without depressive symptoms and with normal weight (P <.001).
- Current smokers with depressive symptoms demonstrated a 3.6-fold increase in the odds of CHD or angina and a 3.5-fold increase in the odds of CHF or MI, relative to never-smokers without depressive symptoms; all associations were statistically significant (P <.001).
Clinical Bottom Line
In adults aged ≥50 years, depressive symptom frequency is a clinically useful cardiovascular risk signal, not just a mental health concern. Patients reporting depressive symptoms plus obesity or current smoking warrant especially close cardiometabolic assessment.
Practice Implications
- In routine visits with adults aged ≥50 years, ask how often patients have felt “down, depressed, or hopeless” over the past two weeks, because risk increased across symptom-frequency categories rather than only at a diagnostic threshold.
- When depressive symptoms are present, review cardiovascular history and modifiable risks explicitly; subtype prevalence was higher in depressed participants for CHD (10.8% vs 8.4%), angina (14.6% vs 11.7%), MI (15.4% vs 12.3%), and CHF (12.5% vs 9.1%).
- Treat obesity and smoking as amplifiers of cardiovascular risk in depressed older adults, since depressive symptoms plus BMI ≥30 kg/m2 were linked to 3.2 times higher odds of CHD or angina and 3.1 times higher odds of CHF or MI, while current smoking plus depressive symptoms was linked to OR =3.6 and OR=3.5, respectively.
- Consider integrated care approaches for older adults with depressive symptoms and cardiometabolic risk, particularly those with obesity or nicotine use, because the study identified these groups as having the highest cardiovascular burden.
